Schedule 13G ownership disclosure
Opexa Therapeutics, Inc.
Security class unavailable · CUSIP: 68372T202
Event date: 2015-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-133285
- Form type
- SC 13G
- Filer
- Anson Funds Management LP
- CIK
- CIK 1491072
- Filed
- Apr 16, 2015
- Reporting period
- Apr 09, 2015
- Description
- Schedule 13G beneficial ownership